111 related articles for article (PubMed ID: 32433403)
21. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
22. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
23. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
24. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
25. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
26. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
29. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
Yang J; Zeng Y
Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
[TBL] [Abstract][Full Text] [Related]
30. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
31. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.
Lee KH; Lee JK; Choi DW; Do IG; Sohn I; Jang KT; Jung SH; Heo JS; Choi SH; Lee KT
Pancreas; 2015 Jul; 44(5):764-8. PubMed ID: 25906450
[TBL] [Abstract][Full Text] [Related]
32. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
33. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
34. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
35. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
Qian J; Zeng L; Jiang X; Zhang Z; Luo X
Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
[TBL] [Abstract][Full Text] [Related]
36. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
37. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Zhang HM; Yang B; Chen HF; Chi XH; Xi YB; Chen XM; Guo B; He PF; Lu XC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):530-535. PubMed ID: 31032588
[TBL] [Abstract][Full Text] [Related]
38. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
39. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
40. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]